RxSight Inc
RXST
Company Profile
Business description
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Contact
100 Columbia
Aliso ViejoCA92656
USAT: +1 949 521-7830
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
461
Stocks News & Analysis
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,986.20 | 49.10 | -0.54% |
| CAC 40 | 8,403.99 | 36.66 | 0.44% |
| DAX 40 | 24,995.81 | 368.92 | 1.50% |
| Dow JONES (US) | 52,319.20 | 136.46 | 0.26% |
| FTSE 100 | 10,497.12 | 12.90 | 0.12% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,213.72 | 393.58 | 1.52% |
| Nikkei 225 | 70,062.32 | 594.21 | 0.86% |
| NZX 50 Index | 13,621.66 | 76.10 | 0.56% |
| S&P 500 | 7,499.36 | 58.93 | 0.79% |
| S&P/ASX 200 | 8,778.70 | 52.80 | -0.60% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |